BioMADE, a headline partner for Bio Innovations North America, has announced a $21.4 million investment across 14 projects aimed at advancing the U.S. bioindustrial manufacturing sector. The funding comes through partnerships with the U.S. Department of Defense and the National Science Foundation.
The announcement, made during BioMADE’s Member Meeting, marks a significant push to strengthen domestic supply chains and establish American leadership in the global bioeconomy. The investment involves 23 member organizations spanning coastal and heartland states, reflecting the breadth of the nation’s growing biotechnology sector.
Douglas Friedman, BioMADE’s Chief Executive Officer, emphasized the urgency of the initiative. “Global competition for bioindustrial manufacturing is at a critical tipping point,” he said. “Many countries are investing heavily in biotechnology innovation and commercialization.”
The projects span three key areas: technology innovation, workforce development, and safety frameworks. Technology initiatives will develop bio-based products including lithium biosorbents for biomining, specialized plastics for 3D printing, and proteins for wound healing. These efforts will leverage artificial intelligence, machine learning, and advanced sensors.
Workforce development represents a major component of the investment. Six projects totaling $9.6 million will create biomanufacturing training programs, including apprenticeships at pilot plants and community college curricula. Some programs specifically target veterans transitioning to civilian careers.
For the first time, the National Science Foundation is partnering with BioMADE to bridge fundamental research and commercial application. NSF will support early-stage research and proof-of-concept work, while BioMADE handles technology maturation and scale-up.
“This public-private collaboration will help realize the potential of fundamental science and engineering research,” said Don Millard, head of NSF’s Directorate for Engineering.
Stephen Recchia, Program Manager for the Department of Defense Manufacturing Innovation Institutes, highlighted the dual benefits of bioindustrial manufacturing. “It has the power to secure domestic supply chains for essential chemicals and materials while reducing reliance on foreign inputs,” he noted.
The projects aim to produce commercially viable bio-based materials from agricultural feedstocks like corn, soy, and sugar beets. This approach could create new markets for American farmers and manufacturing jobs in rural communities.
One project will develop cacao plant cell culture technology to produce chocolate more sustainably. Another focuses on creating low-cost diagnostic tools for disease outbreaks.
Susan Marqusee, NSF Assistant Director for Biological Sciences, noted that industrial biotechnology already contributes over $200 billion to the U.S. economy. These new projects build on that foundation while addressing national security priorities.
The bioindustrial manufacturing sector uses biological systems to convert agricultural feedstocks and waste streams into high-value products including chemicals, materials, fuels, and bioplastics. As global competition intensifies, these investments position the United States to maintain its competitive edge in this rapidly evolving industry.
The post BioMADE invests $21M in U.S. biomanufacturing appeared first on World Bio Market Insights.
